ImmunityBio (IBRX) Enterprise Value Growth (5y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | ImmunityBio | 7.72 Bn | 7.34 Bn | 43.97 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -35.62% |
| Dec 31, 2025 | -20.62% |
| Sep 30, 2025 | -11.96% |
| Jun 30, 2025 | -4.41% |
| Mar 31, 2025 | 5.84% |
| Dec 31, 2024 | -5.86% |
| Sep 30, 2024 | -47.89% |
| Jun 30, 2024 | -20.88% |
| Mar 31, 2024 | -48.48% |
| Dec 31, 2023 | -72.17% |
| Sep 30, 2023 | -17.77% |
| Jun 30, 2023 | 14.12% |
| Mar 31, 2023 | 5.05% |
| Dec 31, 2022 | 3.07% |
| Sep 30, 2022 | 5.11% |
| Jun 30, 2022 | 13.48% |
| Mar 31, 2022 | -0.34% |
| Dec 31, 2021 | -9.90% |
| Sep 30, 2021 | 17.12% |
| Jun 30, 2021 | 13.32% |
| Mar 31, 2021 | 17.88% |
| Dec 31, 2020 | 20.28% |
| Sep 30, 2020 | 16.45% |
| Jun 30, 2020 | -0.44% |
| Mar 31, 2020 | -10.44% |
| Dec 31, 2019 | -13.63% |
| Sep 30, 2019 | -41.90% |
| Jun 30, 2019 | -83.94% |
| Dec 31, 2018 | -118.78% |